Steady Gains Amid Sector Challenges
Apollo Hospitals has demonstrated resilience in a fluctuating market environment, outperforming the broader sector by 0.46% on the day. The stock has recorded gains for five consecutive sessions, accumulating a 3.3% return over this period. This steady upward momentum contrasts with the broader Sensex, which has posted a more modest 1.59% gain over the past week. Despite a slight decline of 2.55% over the last month, the stock’s year-to-date return of 1.67% surpasses the Sensex’s negative 1.92%, signalling relative strength in the current market cycle.
Technical Indicators and Liquidity
From a technical perspective, the stock is trading above its 5-day, 20-day, and 50-day moving averages, indicating short- to medium-term bullishness. However, it remains below the 100-day and 200-day moving averages, suggesting some longer-term resistance levels yet to be overcome. Liquidity remains adequate, with the stock supporting a trade size of approximately ₹4.37 crores based on 2% of its five-day average traded value. Notably, investor participation has slightly waned, with delivery volumes on 05 Feb falling by 15.43% compared to the five-day average, which may reflect cautious positioning by some market participants.
Fast mover alert! This Large Cap from Automobiles - Passeenger just qualified for our Momentum list with stellar technical indicators. Strike while the iron is hot!
- - Recent Momentum qualifier
- - Stellar technical indicators
- - Large Cap fast mover
Robust Financial Health Underpins Confidence
The company’s strong financial metrics provide a solid foundation for its share price appreciation. Apollo Hospitals boasts a high Return on Capital Employed (ROCE) of 16.84%, reflecting efficient management and effective utilisation of capital. Its ability to service debt is also commendable, with a low Debt to EBITDA ratio of 1.48 times, indicating manageable leverage and financial stability.
Long-term growth prospects remain healthy, supported by an annual net sales growth rate of 16.66% and an operating profit growth of 37.14%. The company has consistently delivered positive results for eight consecutive quarters, with quarterly net sales reaching a peak of ₹6,303.50 crores. Operating profit to interest coverage stands robust at 8.59 times, further underscoring operational strength.
Valuation and Institutional Backing
Apollo Hospitals is attractively valued relative to its peers, trading at an enterprise value to capital employed ratio of 7.7. Despite generating a modest 4.30% return over the past year, the company’s profits have surged by 41.3%, resulting in a PEG ratio of 1.5 that suggests reasonable growth expectations are priced in. Institutional investors hold a significant 65.27% stake, reflecting confidence from well-resourced market participants who typically conduct thorough fundamental analysis.
As the largest company in its sector with a market capitalisation of ₹1,02,447 crores, Apollo Hospitals commands a 19.32% share of the sector’s market value. Its annual sales of ₹23,264.70 crores represent 28.25% of the industry, highlighting its dominant position and influence on sector dynamics.
Holding Apollo Hospitals from Hospital? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Conclusion: A Balanced Outlook with Positive Momentum
The recent rise in Apollo Hospitals’ share price is supported by a combination of strong operational performance, attractive valuation metrics, and sustained institutional interest. While the stock faces some technical resistance at longer-term moving averages and a slight dip in investor participation, its consistent quarterly results and dominant sector position provide a compelling case for continued investor confidence. The company’s ability to maintain healthy growth rates in sales and profits, alongside prudent financial management, underpins the positive momentum observed in the market.
Investors should monitor the stock’s ability to break above its 100-day and 200-day moving averages for confirmation of a sustained uptrend, while also considering sector dynamics and broader market conditions. Overall, Apollo Hospitals Enterprise Ltd. remains a key player in the healthcare sector with a performance profile that justifies its recent gains.
Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →
